Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas. - Wikidata - awgldk - TriplyDB

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

http://www.wikidata.org/entity/Q34690946

about

Autologous hematopoietic stem cell transplantation following high dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas Autologous hematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft tissue sarcoma Eribulin in the management of inoperable soft-tissue sarcoma: patient selection and survival Treatment of Adult Soft Tissue Sarcomas: An Overview Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas.A phase II study of tasisulam sodium (LY573636 sodium) as second-line or third-line treatment for patients with unresectable or metastatic soft tissue sarcoma.Sorafenib and dacarbazine in soft tissue sarcoma: a single institution experience.Anthracyclines: cardiotoxicity and its prevention.Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.Outcome analysis in patients with uterine sarcoma Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.Clinical efficacy of vorinostat in a patient with leiomyosarcoma.Doxorubicin and Dacarbazine (AD) Regimen for Soft Tissue Sarcomas High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group Systemic therapy for advanced soft tissue sarcomas: highlighting novel therapies and treatment approaches Sarcomas and pharmacogenetics.Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice Multimodality therapy for metastatic sarcomas confined to the lung.Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline.High-Dose Chemotherapy Followed by Peripheral and/or Bone Marrow Stem Cell Transplant in Patients With Advanced Sarcoma: Experience of a Canadian Centre.Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue Sarcomas Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas.The Experience of the EORTC Soft Tissue and Bone Sarcoma Group.The role of adjuvant therapy in uterine leiomyosarcoma Phase II Study of Temozolomide and Thalidomide in Patients with Unresectable or Metastatic Leiomyosarcoma Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services.Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.Advanced chondrosarcomas: role of chemotherapy and survival.Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience New and emerging therapies for advanced or metastatic soft tissue sarcoma.Novel systemic therapies in advanced liposarcoma: a review of recent clinical trial results Current management options for liposarcoma and challenges for the future.Use of mTOR inhibitors in the treatment of malignancies.Clinicopathological features of breast angiosarcoma.Targeted therapy and promising novel agents for the treatment of advanced soft tissue sarcomas.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.Chemotherapy for soft tissue sarcoma.Hepatic metastases from soft-tissue sarcoma.

P2860

Q24200521-58DFD752-F9F3-4D0E-85C6-F9F265123D08 Q24234049-E60ADB12-5BB5-4AE8-8E58-616B56BA7373 Q24247966-4519EAA7-E506-44E6-A243-FD025D625ED4 Q28074125-18D847CC-B4D7-41C3-B3BD-09B815986B29 Q28088685-DCDFE0B1-AF26-4CC8-9B10-4AEAB9BBA209 Q33343936-BDAEC6B0-A986-4FD8-BD18-AD28A932E26D Q33400959-4D1F09B1-63D9-49D7-82D5-184AFA837D77 Q33404411-A0A3C898-8038-4E98-81A4-A77F608083CA Q33625243-A35C51F1-3E8B-4337-AE7F-5A8921E92148 Q34633368-EE832B66-32E0-4520-9213-827728BA396D Q34647970-905BCE7C-E20D-494C-93EA-D5A31A34AD1B Q35375270-8BA060A5-598B-4999-B60B-9C6099883168 Q35775234-F6116451-044F-42EA-BD51-6E5D45C02DDF Q35789686-C72D875A-FA98-4B16-80CF-35E78E2544C8 Q36052217-A08D4272-9E29-41A0-BD5F-3DE2E7D0AEED Q36115868-856ACE5A-85F9-4724-98F0-6B226B28AD47 Q36144210-15183A0C-6B36-4644-B935-C4B05F6E65A4 Q36249224-D15F5E70-24D4-4F94-B854-EEBC3069FFF6 Q36296826-D374BA35-071D-4A02-94F6-72A75E869DC8 Q36424138-532848D0-2D36-407B-8E07-C15F08764858 Q36674041-A4EB431F-FF78-4433-A043-7AF76C0D2425 Q36674431-1432FE26-1D2D-417E-B20E-19CC867D12E0 Q36674450-2CF77BE9-1F21-4B91-964D-BD44FD51DE4F Q36690873-838E2EEF-529E-4536-9F76-8465DAB17A5C Q36811788-7738197F-F538-440D-9E19-9AE8A41274CA Q36973769-C3ED9CED-19D6-464B-BE9B-0F81CA87ECB5 Q37082346-2B01D5D6-1065-46AC-A315-91CD94364B8D Q37184383-FC25B581-3EB9-44D2-8941-03153D52DDC1 Q37265042-F7004185-FEFB-41CE-9E2E-E8FECF6117E3 Q37743151-F3002798-A071-41C9-AC8E-B3106CAF4792 Q38136098-0AEC6806-8542-4A0A-9761-17CB0E377F58 Q38161734-82569668-5DB1-4F04-A124-FC862C627496 Q38176387-E963EEDA-89A2-47F1-A800-2B1A681E0CAA Q38199196-EDDD52AF-D738-4DB2-B250-5AEEB874307A Q38560911-0A5392BD-60CB-4F70-895E-4993F7D2514E Q38569799-86ABFAE6-BA3A-42E4-8316-3E2E4AAA2860 Q38591828-C95E8129-8F25-4DFD-8BF7-68AD4EA8D0B5 Q38692839-40EEA1D3-6EF0-439F-872A-AD3598F9B8C9 Q38902113-DAE59312-37D0-4100-8C55-286D76DD1A68 Q40511510-9326094C-3E37-4590-AA5B-433FEC3B1612

P2860

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

http://www.wikidata.org/entity/Q34690946

description

1987 nî lūn-bûn

@nan

1987 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@ast

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@en

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@nl

type

label

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@ast

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@en

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@nl

prefLabel

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@ast

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@en

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@nl

P1433

Q34690946-F6E32A54-FECD-4358-80AB-2D603BEA91F9

P1476

Q34690946-87587AD8-3692-403F-8B5D-F6E7DC577F20

P2093

Q34690946-1B857156-04C4-4658-8D59-B9EE76E243FB

Q34690946-2BFD3B3D-D226-4841-B2F4-F2B0FB47CCAC

Q34690946-487C28C2-B7DF-49CC-AD93-46942142793E

Q34690946-78217880-F55A-4B85-9DC9-980C0F7772BE

Q34690946-7F18C4FD-9370-4B1C-B1AA-A763BFD9836E

Q34690946-90C0790D-BB47-48F2-9122-D4974EAB0665

Q34690946-A13E7BFF-0669-4C46-BC2B-4B34618F0AA9

Q34690946-DCCB6248-4F9C-4727-850B-0E2B71F6C006

P304

Q34690946-4CB864D2-E0D7-43FF-9D79-0BBF285CF9AE

P31

Q34690946-63FB583B-8A08-4D02-ACA1-8600788A93CF

P356

Q34690946-B2194D75-64D6-440C-A8D8-05784923DDB4

P407

Q34690946-76DB029F-5A83-4CD8-86C0-5B25C40587D3

P433

Q34690946-18B70051-1331-4770-868C-5B15D22B1E59

P478

Q34690946-4C62D166-67D7-4D49-AE98-898CF5669D85

P577

Q34690946-CA3D3A90-F84F-4609-ADD8-23379F14E9A7

P698

Q34690946-E251D5F9-5248-4FFE-BBA7-9C6181DE5149

P356

JCO.1987.5.6.840

P1433

Journal of Clinical Oncology

P1476

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

@en

P2093

C Rosenbaum

http://www.w3.org/2001/XMLSchema#string

D A Amato

http://www.w3.org/2001/XMLSchema#string

E C Borden

http://www.w3.org/2001/XMLSchema#string

H J Lerner

http://www.w3.org/2001/XMLSchema#string

H T Enterline

http://www.w3.org/2001/XMLSchema#string

M J Shiraki

http://www.w3.org/2001/XMLSchema#string

P P Carbone

http://www.w3.org/2001/XMLSchema#string

R H Creech

http://www.w3.org/2001/XMLSchema#string

P304

840-850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.1987.5.6.840

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

1987-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3585441

http://www.w3.org/2001/XMLSchema#string